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Available online 15 January 2016Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum.Very little
is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available.
Here, we demonstrate the generation of an induced pluripotent stem cell (iPSC) line of a SCA2 patient. The select-
ed clone has been proven to be a bona ﬁde iPSC line, which retains a normal karyotype. Due to its differentiation
potential into neurons, this iPSC line will be a valuable tool in studying a disease-speciﬁc phenotype of SCA2.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Resource TableName of Stem Cell construct H196 clone7stitution University of Copenhagen and Bioneer A/S
erson who created resource Adele G. Marthaler, Benjamin Schmid
ontact person and email Adele G. Marthaler, adele.marthaler@sund.ku.dk
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rigin Human skin ﬁbroblasts
pe of resource Induced pluripotent stem cells; derived
from skin ﬁbroblasts of patient with
spinocerebellar ataxia type 2b-type Cell line
ey transcription factors Episomal plasmids containing hOCT4, hSOX2,
hL-MYC, hKLF4, hLIN28, and shP53 (Addgene
plasmids 27,077, 27,078 and 27,080;
Okita et al., 2011)uthentication Identity and purity of stem cell
line conﬁrmed (Fig. 1)nk to related literature
(direct URL links and
full references)
formation in public databasesIn2. Resource Details
Human skin ﬁbroblasts, obtained by skin biopsy of a symptomatic,
male 52-year-old spinocerebellar type 2 (SCA2) patient (anonymizedpen access article under the CC BY-Nas H196), were reprogrammed using episomal vectors carrying tran-
scripts for human OCT4, SOX2, KLF4, L-MYC, LIN28, and small hairpin
RNA for TP53 (Okita et al., 2011). The clone described in this publication
was termed H196 clone (c) 7. Absence of the reprogramming plasmids
was conﬁrmed by quantitative PCR (qPCR) on genomic DNA (Fig. 1A).
SCA2 is a dominantly inherited neurodegenerative disorder caused
by amutation in the ATXN2 gene. Normal alleles contain 22 CAG repeats
with CAA interruptions (also coding for glutamine), whereas disease
causing alleles contain trinucleotide repeats of 33 ormore CAGs (usually
without any CAA interruptions) (Pulst et al., 1996). The repeat lengths
for patient H196 were determined to be 22 and 36 by fragment length
analysis (data not shown) and conﬁrmed to be present also in iPSC
line H196 c7 by sequencing both alleles individually (Fig. 1B).
Furthermore, expression of key pluripotency genes was observed
both on RNA, as well as protein level, as demonstrated by qRTPCR anal-
ysis and immunocytochemistry, respectively (Fig. 1 C and D). Addition-
ally, the cells had the capacity to form derivatives of all three germ
layers upon embryoid body differentiation (Fig. 1E). Taken together,
this validates the true pluripotent potential of the generated iPSC line.
3. Materials and methods
3.1. Reprogramming using episomal vectors
Fibroblasts were cultured in ﬁbroblast medium, consisting of
Dulbecco's Modiﬁed Eagle Medium (DMEM) supplemented with 10%
fetal bovine serum(FBS), 2mML-glutamine and 1%penicillin and strep-
tomycin (Pen/Strep). 1 x 105 ﬁbroblasts were electroporated with a
total of 1 μg of episomal plasmids containing hOCT4with a short hairpinC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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hSOX2 and hKLF4 (Addgene plasmid 27,078), and hL-MYC and hLIN28
(Addgene plasmid 27,080), (Okita et al., 2011), and cultured in ﬁbro-
blast medium. Electroporation was carried out using a Neon™ elec-
troporation device with two pulses at 1200 V for 20 ms (Life
Technologies). One week after electroporation, ﬁbroblasts were
trypsinized and split 1:2 onto matrigel-coated dishes (BD Biosci-
ences) and cultured in E8medium (Gibco) under hypoxic conditions.
After four weeks, primary iPSC colonies were picked to establish sta-
ble clones.
3.2. Integration of episomal vectors
DNA for integration analysis was puriﬁed from ﬁbroblasts and iPSCs
using the DNeasy Blood and Tissue kit (Qiagen). Data was plotted using
the delta delta Ct algorithm, 2(−ΔΔCt) with ﬁbroblasts and GAPDH as
references. The following primers were used:O
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6 c7 by embryoid body formation. Scale b5′-CATTCAAACTGAGGTAAGGG-3’
CT4 transgene rev 5′-TAGCGTAAAAGGAGCAACATAG-3’
X2 transgene for 5′-TTCACATGTCCCAGCACTACCAGA-3’
X2 transgene rev 5′-TTTGTTTGACAGGAGCGACAAT-3’
N28 transgene for 5′-AGCCATATGGTAGCCTCATGTCCGC-3’
N28 transgene rev 5′-TAGCGTAAAAGGAGCAACATAG-3’LI3.3. Sequencing
Sanger sequencing of a 300 base pair region around the CAG repeat
region of the ATXN2 gene was carried out in an ABI PRISM 310 Genetic
Analyzer using the primers SCA2 seq2 forward 5′-CTTGGTCTCGGCGG
GC-3′ and SCA2 seq2 reverse 5′-GAGGAGACCGAGGACGAGG-3′.
3.4. RNA extraction, cDNA synthesis, and quantitative real-time PCR (qRT-PCR)
RNA was extracted using RNeasy Mini (QIAGEN) and cDNA synthe-
sis was performed using Revert Aid First Strand cDNA synthesis kit
(Thermo Scientiﬁc) according to the manufacturers' protocols. qRT-
PCR was carried out using LightCycler 480 SYBR Green I Master
(Roche). Data was plotted using the delta delta Ct algorithm, 2(−ΔΔCt).
The following primers were used:CT4 for 5′-CCCCAGGGCCCCATTTTGGTACC-3’
CT4 rev 5′-ACCTCAGTTTGAATGCATGGGAGAGC-3’
X2 for 5′-TTCACATGTCCAGCACTACCAGA-3’
X2 rev 5′-TCACATGTGTGAGAGGGGCAGTGTGC-3’
ANOG for 5′-AAAGAATCTTCACCTATGCC-3’
ANOG rev 5′-GAAGGAAGAGGAGAGACAGT-3’
EX1 for 5′-TTTCTGAGTACGTGCCCAGGCAA-3’
EX1 rev 5′-CTCTGAGAAAGCATCTCTCCTTC-3’
N28 for 5′-AGCCATATGGTAGCCTCATGTCCGC-3’
N28 rev 5′-TCAATTCTGTGCCTCCGGGAGCAGGGTAGG-3’
CTB for 5′-TCAAGATCATTGCTCCTCCTGAG-3’
CTB rev 5′-ACATCTGCTGGAAGGTGGACA-3’
PL13A for 5′-TTCCAAGCGGCTGCCGAAGA-3’
PL13A rev 5′-TTCCGGCCCAGCAGTACCTGT-3’
SP90AB1 for 5′-TCCGGCGCAGTGTTGGGAC-3’
SP90AB1 rev 5′-TCCATGGTGCACTTCCTCAGGC-3’
USB for 5′-TCCGCGCCGACTTCTCTGACA-3’
USB rev 5′-AAATGCCGCAGACGCCAGTCC-3′.Gnormal karyotype. (A) Absence of reprogramm
rated ﬁbroblasts served as positive and negative
ame plasmid, shp53, KLF4, and L-Myc are repres
cleotide repeats, respectively, highlighted in blu
d as a negative control. Error bars indicate stand
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s representative of the three germ layers, TUBB
ars, 100 μm. (F) Chromosome analysis of H196 c3.5. Immunocytochemistry
Immunocytochemistry was performed as previously described
(Marthaler et al., 2013). The following primary antibodies were used:
Anti-OCT4 (Santa Cruz, sc 8628); anti-NANOG (Peprotech, 500P236);
anti-TRA1-60 (BioLegend, 330,602); anti-SSEA4 (BioLegend, 330,402);
anti-TUBB3 (Millipore, MAB1637); anti-SMA (Dako, M0851), anti-
SOX17 (Santa Cruz, sc77355); all 1:500. Secondary antibodies used
were: Alexa Fluor 594 rabbit anti-goat (A21223) and goat anti-rabbit
(A11072), Alexa Fluor 488 donkey anti-rabbit (A21206), donkey
anti-goat (A11055), and goat anti-mouse (A11017), all 1:2000, (all
Invitrogen).
3.6. Embryoid body differentiation
iPSCs growing in E8 medium (Gibco) on matrigel (Corning Bio-
science) were dissociated with EDTA (Gibco) and allowed to form ag-
gregates in none-coated cell culture dishes. On day 3, aggregates were
transferred to matrigel-coated dishes andmediumwas switched to dif-
ferentiation medium: DMEM/F12 containing 20% FBS, L-glutamine, and
non-essential amino acids (all Gibco) for meso- and endoderm induc-
tion, or DMEM/F12 containing 50% neurobasal medium, B27, N2, and
L-glutamine (all Gibco) for ectoderm induction. Cells were ﬁxed for im-
munocytochemistry on day 14.
3.7. Veriﬁcation and Authentication
An intact genome with no detectable abnormalities was demon-
strated by karyotyping using G-banding (Fig. 1F). Analysis was per-
formed by Cell Guidance Systems, Cambridge, UK.
3.8. Ethical approval
The studywas approved by the regional scientiﬁc ethical committee
in the Capital Region of Denmark (RH), (protocol number H-4-2011-
157), Copenhagen, Denmark, andwritten informed consentwas obtain-
ed in all cases.
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